233 related articles for article (PubMed ID: 32070418)
1. Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice.
Jury N; Abarzua S; Diaz I; Guerra MV; Ampuero E; Cubillos P; Martinez P; Herrera-Soto A; Arredondo C; Rojas F; Manterola M; Rojas A; Montecino M; Varela-Nallar L; van Zundert B
Clin Epigenetics; 2020 Feb; 12(1):32. PubMed ID: 32070418
[TBL] [Abstract][Full Text] [Related]
2. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
3. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
[TBL] [Abstract][Full Text] [Related]
4. Repeated mild traumatic brain injury triggers pathology in asymptomatic C9ORF72 transgenic mice.
Kahriman A; Bouley J; Tuncali I; Dogan EO; Pereira M; Luu T; Bosco DA; Jaber S; Peters OM; Brown RH; Henninger N
Brain; 2023 Dec; 146(12):5139-5152. PubMed ID: 37527465
[TBL] [Abstract][Full Text] [Related]
5. DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD.
Fu X; Zhang Z; Hayes LR; Wright N; Asbury J; Li S; Ye Y; Sun S
Exp Neurol; 2024 Jun; 376():114768. PubMed ID: 38556190
[TBL] [Abstract][Full Text] [Related]
6. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD.
Esanov R; Cabrera GT; Andrade NS; Gendron TF; Brown RH; Benatar M; Wahlestedt C; Mueller C; Zeier Z
Mol Neurodegener; 2017 Jun; 12(1):46. PubMed ID: 28606110
[TBL] [Abstract][Full Text] [Related]
7. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
8. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mäger I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
Brain; 2017 Apr; 140(4):887-897. PubMed ID: 28334866
[TBL] [Abstract][Full Text] [Related]
9. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model.
Nguyen L; Montrasio F; Pattamatta A; Tusi SK; Bardhi O; Meyer KD; Hayes L; Nakamura K; Banez-Coronel M; Coyne A; Guo S; Laboissonniere LA; Gu Y; Narayanan S; Smith B; Nitsch RM; Kankel MW; Rushe M; Rothstein J; Zu T; Grimm J; Ranum LPW
Neuron; 2020 Feb; 105(4):645-662.e11. PubMed ID: 31831332
[TBL] [Abstract][Full Text] [Related]
10. Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models.
Liang C; Shao Q; Zhang W; Yang M; Chang Q; Chen R; Chen JF
Hum Mol Genet; 2019 Dec; 28(23):3940-3953. PubMed ID: 31625563
[TBL] [Abstract][Full Text] [Related]
11. Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD.
Westergard T; Jensen BK; Wen X; Cai J; Kropf E; Iacovitti L; Pasinelli P; Trotti D
Cell Rep; 2016 Oct; 17(3):645-652. PubMed ID: 27732842
[TBL] [Abstract][Full Text] [Related]
12. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.
Licata NV; Cristofani R; Salomonsson S; Wilson KM; Kempthorne L; Vaizoglu D; D'Agostino VG; Pollini D; Loffredo R; Pancher M; Adami V; Bellosta P; Ratti A; Viero G; Quattrone A; Isaacs AM; Poletti A; Provenzani A
EMBO J; 2022 Jan; 41(1):e105026. PubMed ID: 34791698
[TBL] [Abstract][Full Text] [Related]
13. An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD.
Bauer CS; Cohen RN; Sironi F; Livesey MR; Gillingwater TH; Highley JR; Fillingham DJ; Coldicott I; Smith EF; Gibson YB; Webster CP; Grierson AJ; Bendotti C; De Vos KJ
Acta Neuropathol; 2022 Sep; 144(3):437-464. PubMed ID: 35876881
[TBL] [Abstract][Full Text] [Related]
14. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
15. PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS/FTD neurons.
Milioto C; Carcolé M; Giblin A; Coneys R; Attrebi O; Ahmed M; Harris SS; Lee BI; Yang M; Ellingford RA; Nirujogi RS; Biggs D; Salomonsson S; Zanovello M; de Oliveira P; Katona E; Glaria I; Mikheenko A; Geary B; Udine E; Vaizoglu D; Anoar S; Jotangiya K; Crowley G; Smeeth DM; Adams ML; Niccoli T; Rademakers R; van Blitterswijk M; Devoy A; Hong S; Partridge L; Coyne AN; Fratta P; Alessi DR; Davies B; Busche MA; Greensmith L; Fisher EMC; Isaacs AM
Nat Neurosci; 2024 Apr; 27(4):643-655. PubMed ID: 38424324
[TBL] [Abstract][Full Text] [Related]
16. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration.
Solomon DA; Stepto A; Au WH; Adachi Y; Diaper DC; Hall R; Rekhi A; Boudi A; Tziortzouda P; Lee YB; Smith B; Bridi JC; Spinelli G; Dearlove J; Humphrey DM; Gallo JM; Troakes C; Fanto M; Soller M; Rogelj B; Parsons RB; Shaw CE; Hortobágyi T; Hirth F
Brain; 2018 Oct; 141(10):2908-2924. PubMed ID: 30239641
[TBL] [Abstract][Full Text] [Related]
17. C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner.
Shao Q; Liang C; Chang Q; Zhang W; Yang M; Chen JF
Acta Neuropathol Commun; 2019 Mar; 7(1):32. PubMed ID: 30832726
[No Abstract] [Full Text] [Related]
18. c-Jun N-Terminal Kinase Promotes Stress Granule Assembly and Neurodegeneration in C9orf72-Mediated ALS and FTD.
Sahana TG; Chase KJ; Liu F; Lloyd TE; Rossoll W; Zhang K
J Neurosci; 2023 Apr; 43(17):3186-3197. PubMed ID: 37015810
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
20. Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice.
Pattamatta A; Nguyen L; Olafson HR; Scotti MM; Laboissonniere LA; Richardson J; Berglund JA; Zu T; Wang ET; Ranum LPW
Hum Mol Genet; 2021 Feb; 29(24):3900-3918. PubMed ID: 33378537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
